Collectively, data from most previous publications and the preliminary observations from the present study suggest that the expression of ROR1 may be related to poor prognosis and disease aggressiveness in DLBCL, a finding which is in line with reports in a variety of other malignancies. This evidence concerns the gene ROR1 and diffuse large B-cell lymphoma.